Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Axokine use in retinal degeneration covered in new patent

Sep. 23, 1997

Initial phase III results reported for KeraVision Ring

Sep. 17, 1997

AMO Array Multifocal IOL approved for marketing in U.S.

Sep. 11, 1997

Tolmetin eyedrop formulation evaluated in rabbits

Sep. 9, 1997

Improved IOP-lowering prostaglandin analogues from Alcon

Sep. 4, 1997

Alcon reports new agents for controlling IOP

Aug. 26, 1997

CAT's anti-TGF-beta2 antibody approved for phase I/IIa trials

Aug. 26, 1997

FDA approves expansion of Sunrise Technologies' hyperopia study

Aug. 26, 1997

InSite Vision initiates phase II study of ISV-120

Aug. 21, 1997

Generic levobunolol approved in Canada

Aug. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...